Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-12-26

Clinical Trial Update: Clozapine for Cannabis Use in Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 trial updates the use of clozapine for cannabis use in individuals with schizophrenia; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clozapine (Clozapine)

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Schizophrenia, Cannabis Abuse | Phase 4 | Status: COMPLETED | Results posted: 2019-12-26